Nexvet Biopharma Ord (NVET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -19,365 | -11,857 | -6,710 | -3,241 |
| Depreciation Amortization | 516 | 154 | 56 | 11 |
| Other Working Capital | 2,304 | -1,230 | 390 | -442 |
| Other Operating Activity | 1,762 | 2,081 | 320 | 710 |
| Operating Cash Flow | $-14,783 | $-10,852 | $-5,944 | $-2,962 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -4,927 | -294 | -512 | -54 |
| Purchase Sale Intangibles | -64 | -19 | -2 | N/A |
| Other Investing Activity | -64 | -19 | -2 | 0 |
| Investing Cash Flow | $-4,991 | $-313 | $-514 | $-54 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 20 | 37,970 | 37 | N/A |
| Other Financing Activity | 0 | 0 | 35,664 | 3,392 |
| Financing Cash Flow | $20 | $37,970 | $35,701 | $3,392 |
| Exchange Rate Effect | -798 | -4,813 | 315 | 88 |
| Beginning Cash Position | 52,033 | 30,041 | 483 | 19 |
| End Cash Position | 31,481 | 52,033 | 30,041 | 483 |
| Net Cash Flow | $-20,552 | $21,992 | $29,558 | $464 |
| Free Cash Flow | ||||
| Operating Cash Flow | -14,783 | -10,852 | -5,944 | -2,962 |
| Capital Expenditure | -4,927 | -294 | -512 | -54 |
| Free Cash Flow | -19,710 | -11,146 | -6,456 | -3,016 |